1. Canadian product monograph for Cyklokapron updated with risks

   News item 12 February 2022 Pages: 1 - 1

2. COVID-19 vaccine errors dominate ISMP's list of top 10 safety concerns for 2021

   News item 12 February 2022 Pages: 2 - 2

3. FDA investigates umbralisib-related deaths

   News item 12 February 2022 Pages: 3 - 3

4. PMDA issues revision of precautions for levonorgestrel

   Unknown 12 February 2022 Pages: 4 - 4

5. Updated Canadian product monograph for clarithromycin

   News item 12 February 2022 Pages: 5 - 5

6. Voluntary recall of AuroMedics' polymyxin-B injection due to contamination

   News item 12 February 2022 Pages: 6 - 6

7. Attempted suicide by overdosing increases risk of preterm birth

   Clinical study 12 February 2022 Pages: 7 - 7

8. Medication-related hospitalisation in Australia

   Clinical study 12 February 2022 Pages: 8 - 8

9. mRNA COVID-19 vaccines safe in patients with previous COVID-19 infections

   Clinical study 12 February 2022 Pages: 9 - 9

10. Penicillamine-related blood, kidney and skin disorders

    Clinical study 12 February 2022 Pages: 10 - 10

11. Tacrolimus-induced encephalopathy resolves with discontinuation after paediatric LDLT

    Clinical study 12 February 2022 Pages: 11 - 11

12. Tofacitinib increases risk of MACE and cancer versus TNF inhibitors

    Clinical study 12 February 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 12 February 2022 Pages: 13 - 13

14. Abacavir/dolutegravir/lamivudine

    Case report 12 February 2022 Pages: 14 - 14

15. Abiraterone-acetate

    Case report 12 February 2022 Pages: 15 - 15

16. Aciclovir/imiquimod/valaciclovir

    Case report 12 February 2022 Pages: 16 - 16

17. Ad26.cov2-s/immune-globulin

    Case report 12 February 2022 Pages: 17 - 17

18. Adalimumab/infliximab

    Case report 12 February 2022 Pages: 18 - 18

19. Adalimumab/prednisolone

    Case report 12 February 2022 Pages: 19 - 19

20. Alendronic acid

    Case report 12 February 2022 Pages: 20 - 20

21. Allopurinol/dexamethasone/thalidomide

    Case report 12 February 2022 Pages: 21 - 21

22. Alprostadil/infliximab/methotrexate

    Case report 12 February 2022 Pages: 22 - 22

23. Aminocaproic-acid

    Case report 12 February 2022 Pages: 23 - 23

24. Amiodarone

    Case report 12 February 2022 Pages: 24 - 24

25. Amiodarone/azithromycin interaction

    Case report 12 February 2022 Pages: 25 - 25

26. Amiodarone/mexiletine/sotalol

    Case report 12 February 2022 Pages: 26 - 26

27. Amlodipine overdose

    Case report 12 February 2022 Pages: 27 - 27

28. Amoxicillin/clavulanic-acid/sodium-thiosulfate

    Case report 12 February 2022 Pages: 28 - 28

29. Amphotericin-B-liposomal/dexamethasone/methylprednisolone

    Case report 12 February 2022 Pages: 29 - 29

30. Analgesics

    Case report 12 February 2022 Pages: 30 - 30

31. Anti-CD19-CAR-transduced-T-cells/blinatumomab/methotrexate

    Case report 12 February 2022 Pages: 31 - 31

32. Antiarrhythmics

    Case report 12 February 2022 Pages: 32 - 32

33. Antibacterials

    Case report 12 February 2022 Pages: 33 - 33

34. Antibacterials

    Case report 12 February 2022 Pages: 34 - 34

35. Antibacterials

    Case report 12 February 2022 Pages: 35 - 35

36. Antibacterials and antiviral

    Case report 12 February 2022 Pages: 36 - 36

37. Antibacterials/antiepileptic-drugs/lorazepam

    Case report 12 February 2022 Pages: 37 - 37

38. Antibacterials/antiepileptics

    Case report 12 February 2022 Pages: 38 - 38

39. Antibacterials/vancomycin

    Case report 12 February 2022 Pages: 39 - 39

40. Antidepressants

    Case report 12 February 2022 Pages: 40 - 40

41. Antiepileptic drugs/immune-globulin

    Case report 12 February 2022 Pages: 41 - 41

42. Antifungals/cytarabine/daunorubicin

    Case report 12 February 2022 Pages: 42 - 42

43. Antileprotics/antituberculars/antivirals

    Case report 12 February 2022 Pages: 43 - 43

44. Antineoplastics

    Case report 12 February 2022 Pages: 44 - 44

45. Antineoplastics

    Case report 12 February 2022 Pages: 45 - 45

46. Antineoplastics

    Case report 12 February 2022 Pages: 46 - 46

47. Antineoplastics

    Case report 12 February 2022 Pages: 47 - 47

48. Antineoplastics

    Case report 12 February 2022 Pages: 48 - 48

49. Antineoplastics/folinic acid

    Case report 12 February 2022 Pages: 49 - 49

50. Antineoplastics/immunosuppressants/hydroxychloroquine

    Case report 12 February 2022 Pages: 50 - 50